Non-nucleoside reverse transcriptase inhibitors

Details for Australian Patent Application No. 2006280194 (hide)

Owner Merck & Co., Inc.

Inventors Williams, Theresa M.; Zhang, Xu-Fang

Agent Spruson & Ferguson

Pub. Number AU-A-2006280194

PCT Pub. Number WO2007/021629

Priority 60/707,337 11.08.05 US

Filing date 7 August 2006

Wipo publication date 22 February 2007

International Classifications

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/021629 Priority application(s): WO2007/021629

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006280199-Inspection system and associated method

2006280182-Dosage efficient, storage stable compositions for reducing chromium (VI) in cement